메뉴 건너뛰기




Volumn 59, Issue 4, 2010, Pages 212-219

Help patients with chronic kidney disease stave off dialysis

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THYROID HORMONE; VITAMIN D;

EID: 77951279995     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (2)

References (38)
  • 4
    • 33745052469 scopus 로고    scopus 로고
    • Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: An Upstate New York Practice-based Research Network (UNYNET) study
    • Fox CH, Brooks A, Zayas LE, et al. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006;19:54-61. (Pubitemid 44046994)
    • (2006) Journal of the American Board of Family Medicine , vol.19 , Issue.1 , pp. 54-61
    • Fox, C.H.1    Brooks, A.2    Zayas, L.E.3    McClellan, W.4    Murray, B.5
  • 6
    • 20544467918 scopus 로고    scopus 로고
    • Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
    • Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489-495.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 489-495
    • Foley, R.N.1    Murray, A.M.2    Li, S.3
  • 8
    • 0031044756 scopus 로고    scopus 로고
    • Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines
    • McClellan WM, Knight DF, Karp H, et al. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis. 1997;29:368-375. (Pubitemid 27106558)
    • (1997) American Journal of Kidney Diseases , vol.29 , Issue.3 , pp. 368-375
    • McClellan, W.M.1    Knight, D.F.2    Karp, H.3    Brown, W.W.4
  • 10
    • 33746092054 scopus 로고    scopus 로고
    • Identification and referral of patients with progressive CKD: A national study
    • Boulware LE, Troll MU, Jaar BG, et al. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48:192-204.
    • (2006) Am J Kidney Dis , vol.48 , pp. 192-204
    • Boulware, L.E.1    Troll, M.U.2    Jaar, B.G.3
  • 12
    • 15044356747 scopus 로고    scopus 로고
    • Why patients with progressing kidney disease are referred late to the nephrologist: On causes and proposals for improvement
    • DOI 10.1093/ndt/gfh709
    • Wauters JP, Lameire N, Davison A, et al. Why patients with progressing kidney disease are referred late to the nephrologists: on causes and proposals for improvement. Nephrol Dial Transplant. 2005;20:490-496. (Pubitemid 40378416)
    • (2005) Nephrology Dialysis Transplantation , vol.20 , Issue.3 , pp. 490-496
    • Wauters, J.-P.1    Lameire, N.2    Davison, A.3    Ritz, E.4
  • 15
    • 34447650790 scopus 로고    scopus 로고
    • Testing for chronic kidney disease: A position statement from the National Kidney Foundation
    • Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169-180.
    • (2007) Am J Kidney Dis , vol.50 , pp. 169-180
    • Vassalotti, J.A.1    Stevens, L.A.2    Levey, A.S.3
  • 16
    • 68749119964 scopus 로고    scopus 로고
    • Cardiovascular disease in chronic kidney disease
    • Saran AM, DuBose TD Jr. Cardiovascular disease in chronic kidney disease. Ther Adv Cardiovasc Dis. 2008;2:425-434.
    • (2008) Ther Adv Cardiovasc Dis , vol.2 , pp. 425-434
    • Saran, A.M.1    Dubose Jr., T.D.2
  • 17
    • 77951261213 scopus 로고    scopus 로고
    • Available at: Accessed January 25, 2009
    • Mental Health America. Fact sheet: co-occurring disorders and depression. Available at: http://www.nmha.org/index.cfm?objectid=C7DF94C1-1372-4D20- C8FE4E509C20471B. Accessed January 25, 2009.
    • Fact Sheet: Co-occurring Disorders and Depression
  • 18
    • 58149359066 scopus 로고    scopus 로고
    • Course of depression and anxiety diagnosis in patients treated with hemodialysis: A 16-month follow-up
    • Cukor D, Coplan J, Brown C, et al. Course of depression and anxiety diagnosis in patients treated with hemodialysis: a 16-month follow-up. Am Soc Nephrol. 2008;3:1752-1758.
    • (2008) Am Soc Nephrol , vol.3 , pp. 1752-1758
    • Cukor, D.1    Coplan, J.2    Brown, C.3
  • 19
    • 4544336905 scopus 로고    scopus 로고
    • Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end stage renal disease (CALVIDIA Study)
    • Lopez Revuelta K, Garcia Lopez FJ, de Alvaro Moreno F, et al. Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end stage renal disease (CALVIDIA Study). Nephrol Dial Transplant. 2004;19:2347-2353.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 2347-2353
    • Lopez Revuelta, K.1    Garcia Lopez, F.J.2    De Alvaro Moreno, F.3
  • 20
    • 54049152837 scopus 로고    scopus 로고
    • A primary care approach: Managing depression in the face of chronic medical conditions
    • Ford DE. A primary care approach: Managing depression in the face of chronic medical conditions. Am J Med. 2008;121(suppl 2):S38-S44.
    • (2008) Am J Med , vol.121 , Issue.SUPPL. 2
    • Ford, D.E.1
  • 21
    • 33846973650 scopus 로고    scopus 로고
    • Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease
    • DOI 10.1111/j.1440-1797.2006.00749.x
    • Ferrari P. Prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrol. 2007;12:81-89. (Pubitemid 46246558)
    • (2007) Nephrology , vol.12 , Issue.1 , pp. 81-89
    • Ferrari, P.1
  • 22
    • 65249101280 scopus 로고    scopus 로고
    • The prevalence of low triiodo-thyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone
    • Song SH, Kwak IS, Lee DW, et al. The prevalence of low triiodo-thyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone. Nephrol Dial Transplant. 2009;24:1534-1538.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 1534-1538
    • Song, S.H.1    Kwak, I.S.2    Lee, D.W.3
  • 23
    • 58149156441 scopus 로고    scopus 로고
    • Vitamin D levels and patient outcome in chronic kidney disease
    • Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009;75:88-95.
    • (2009) Kidney Int , vol.75 , pp. 88-95
    • Ravani, P.1    Malberti, F.2    Tripepi, G.3
  • 24
    • 34547149622 scopus 로고    scopus 로고
    • Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients
    • DOI 10.1080/08860220701391670, PII 780773625
    • Cupisti A, Aparicio M, Barsotti G. Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients. Ren Fail. 2007;29:529-534. (Pubitemid 47123807)
    • (2007) Renal Failure , vol.29 , Issue.5 , pp. 529-534
    • Cupisti, A.1    Aparicio, M.2    Barsotti, G.3
  • 25
    • 1542331373 scopus 로고    scopus 로고
    • Medical nutrition therapy in chronic kidney failure: Integrating clinical practice guidelines
    • Beto JA, Bansal VK. Medical nutrition therapy in chronic kidney failure: Integrating clinical practice guidelines. J Am Diet Assoc. 2004;104:404-409.
    • (2004) J Am Diet Assoc , vol.104 , pp. 404-409
    • Beto, J.A.1    Bansal, V.K.2
  • 26
    • 58049199368 scopus 로고    scopus 로고
    • The new role of calcimimetics as vasculotropic agents
    • Al-Aly Z. The new role of calcimimetics as vasculotropic agents. Kidney Int. 2009;75:9-12.
    • (2009) Kidney Int , vol.75 , pp. 9-12
    • Al-Aly, Z.1
  • 27
    • 75149125787 scopus 로고    scopus 로고
    • Anemia and chronic kidney disease: What's the connection?
    • Taliercio JJ. Anemia and chronic kidney disease: what's the connection? J Fam Pract. 2010;59:14-18.
    • (2010) J Fam Pract , vol.59 , pp. 14-18
    • Taliercio, J.J.1
  • 28
    • 36448979949 scopus 로고    scopus 로고
    • Outcomes in patients with chronic kidney disease referred late to nephrologists: A meta-analysis
    • Chan MR, Dall AT, Fletcher KE, et al. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med. 2007;120:1063-1070.
    • (2007) Am J Med , vol.120 , pp. 1063-1070
    • Chan, M.R.1    Dall, A.T.2    Fletcher, K.E.3
  • 30
    • 0348103712 scopus 로고    scopus 로고
    • Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance
    • DOI 10.1016/j.jada.2003.10.016
    • Durose CL, Holdsworth M, Watson V, et al. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. Am Diet Assoc. 2004;104:35-41. (Pubitemid 38058296)
    • (2004) Journal of the American Dietetic Association , vol.104 , Issue.1 , pp. 35-41
    • Durose, C.L.1    Holdsworth, M.2    Watson, V.3    Przygrodzka, F.4
  • 31
    • 33646522211 scopus 로고    scopus 로고
    • Disease management interventions II: What else is in the black box?
    • Linden A, Butterworth SW, Roberts N. Disease management interventions II: what else is in the black box? Dis Manage. 2006;9:73-85.
    • (2006) Dis Manage , vol.9 , pp. 73-85
    • Linden, A.1    Butterworth, S.W.2    Roberts, N.3
  • 32
    • 33646477119 scopus 로고    scopus 로고
    • Therapist influence on client language during motivational interviewing sessions
    • Moyers TB, Martin T. Therapist influence on client language during motivational interviewing sessions. J Subst Abuse Treat. 2006;30:245-251.
    • (2006) J Subst Abuse Treat , vol.30 , pp. 245-251
    • Moyers, T.B.1    Martin, T.2
  • 33
    • 34548747483 scopus 로고    scopus 로고
    • Client language as a mediator of motivational interviewing efficacy: Where is the evidence?
    • Moyers TB, Martin T, Christopher PJ, et al. Client language as a mediator of motivational interviewing efficacy: where is the evidence? Alcohol Clin Exp Res. 2007;31(10 suppl):40s-47s.
    • (2007) Alcohol Clin Exp Res , vol.31 , Issue.10 SUPPL.
    • Moyers, T.B.1    Martin, T.2    Christopher, P.J.3
  • 36
    • 0020584071 scopus 로고
    • Motivational interviewing with problem drinkers
    • Miller WR. Motivational interviewing with problem drinkers. Behav Psychother. 1983;11:147-172.
    • (1983) Behav Psychother , vol.11 , pp. 147-172
    • Miller, W.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.